BCM
RMD icon

Boreal Capital Management’s ResMed RMD Stock Holding History

Boreal Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.76K Hold
39
– – 0.01% 353
2025
Q4 		$9.39K Hold
39
– – 0.01% 354
2025
Q3 		$10.7K Buy
+39
New +$10.7K 0.01% 343

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boreal Capital Management's RMD Position: Q1 2026 in Review

Boreal Capital Management held its ResMed (RMD) position steady in Q1 2026 at 39 shares worth $8.76K. The position accounts for 0.01% of the portfolio, ranked #353.

Boreal Capital Management first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $10.7K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Boreal Capital Management held 39 shares of ResMed worth $8.76K as of Q1 2026.
  • Boreal Capital Management left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.01% of Boreal Capital Management's portfolio in Q1 2026, its #353 holding.
  • Boreal Capital Management first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
  • Boreal Capital Management's ResMed position peaked at $10.7K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Boreal Capital Management's 13F filing for Q1 2026, filed 14 May 2026.